{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:46:43Z","timestamp":1791218803324,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00520-023-07890-5","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T07:39:02Z","timestamp":1687592342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hematologic toxicities, sarcopenia, and body composition change in breast cancer patients undergoing neoadjuvant chemotherapy"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-161X","authenticated-orcid":false,"given":"Min Kyeong","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardith","family":"Doorenbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieon","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,24]]},"reference":[{"issue":"39","key":"7890_CR1","doi-asserted-by":"publisher","first-page":"25714","DOI":"10.18632\/oncotarget.25394","volume":"9","author":"F Mazzuca","year":"2018","unstructured":"Mazzuca F, Onesti CE, Roberto M, Di Girolamo M, Botticelli A, Begini P, Strigari L, Marchetti P, Muscaritoli M (2018) Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines. Oncotarget 9(39):25714\u201325722. https:\/\/doi.org\/10.18632\/oncotarget.25394","journal-title":"Oncotarget"},{"issue":"1","key":"7890_CR2","doi-asserted-by":"publisher","first-page":"e0169136","DOI":"10.1371\/journal.pone.0169136","volume":"12","author":"J Nattenm\u00fcller","year":"2017","unstructured":"Nattenm\u00fcller J, Wochner R, Muley T, Steins M, Hummler S, Teucher B, Wiskemann J, Kauczor HU, Wielp\u00fctz MO, Heussel CP (2017) Prognostic impact of CT-quantified muscle and fat distribution before and after first-line-chemotherapy in lung cancer patients. PLoS One 12(1):e0169136. https:\/\/doi.org\/10.1371\/journal.pone.0169136","journal-title":"PLoS One"},{"issue":"5","key":"7890_CR3","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/SLA.0000000000002398","volume":"266","author":"JA Elliott","year":"2017","unstructured":"Elliott JA, Doyle SL, Murphy CF, King S, Guinan EM, Beddy P, Ravi N, Reynolds JV (2017) Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg 266(5):822\u2013830. https:\/\/doi.org\/10.1097\/SLA.0000000000002398","journal-title":"Ann Surg"},{"issue":"1","key":"7890_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4673-2","volume":"18","author":"T Kobayashi","year":"2018","unstructured":"Kobayashi T, Kawai H, Nakano O, Abe S, Kamimura H, Sakamaki A, Kamimura K, Tsuchiya A, Takamura M, Yamagiwa S, Terai S (2018) Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies. BMC Cancer 18(1):1\u20139. https:\/\/doi.org\/10.1186\/s12885-018-4673-2","journal-title":"BMC Cancer"},{"key":"7890_CR5","doi-asserted-by":"publisher","first-page":"100154","DOI":"10.1016\/j.ctarc.2019.100154","volume":"21","author":"F Rossi","year":"2019","unstructured":"Rossi F, Valdora F, Bignotti B, Torri L, Succio G, Tagliafico AS (2019) Evaluation of body computed tomography-determined sarcopenia in breast cancer patients and clinical outcomes: a systematic review. Cancer Treat Res Commun 21:100154. https:\/\/doi.org\/10.1016\/j.ctarc.2019.100154","journal-title":"Cancer Treat Res Commun"},{"issue":"1","key":"7890_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-6645-6","volume":"20","author":"XM Zhang","year":"2020","unstructured":"Zhang XM, Dou QL, Zeng Y, Yang Y, Cheng AS, Zhang WW (2020) Sarcopenia as a predictor of mortality in women with breast cancer: a meta-analysis and systematic review. BMC Cancer 20(1):1\u201311. https:\/\/doi.org\/10.1186\/s12885-020-6645-6","journal-title":"BMC Cancer"},{"issue":"3","key":"7890_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10549-019-05352-3","volume":"177","author":"GF Aleixo","year":"2019","unstructured":"Aleixo GF, Williams GR, Nyrop KA, Muss HB, Shachar SS (2019) Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review. Breast Cancer Res Treat 177(3):569\u2013579. https:\/\/doi.org\/10.1007\/s10549-019-05352-3","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"7890_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10549-017-4574-0","volume":"168","author":"HN Rier","year":"2018","unstructured":"Rier HN, Jager A, Sleijfer S, van Rosmalen J, Kock MCJM, Levin MD (2018) Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer. Breast Cancer Res Treat 168(1):95\u2013105. https:\/\/doi.org\/10.1007\/s10549-017-4574-0","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"7890_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-022-09443-1","volume":"22","author":"M Amitani","year":"2022","unstructured":"Amitani M, Oba T, Kiyosawa N, Morikawa H, Chino T, Soma A, Shimizu T, Ohno K, Ono M, Ito T, Kanai T (2022) Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer. BMC Cancer 22(1):1\u201311. https:\/\/doi.org\/10.1186\/s12885-022-09443-1","journal-title":"BMC Cancer"},{"issue":"1","key":"7890_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-022-09312-x","volume":"22","author":"R Tang","year":"2022","unstructured":"Tang R, Deng JP, Zhang L, Zhang WW, Sun JY, Chi F, Zhang J, Wu SG, He ZY (2022) Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy. BMC Cancer 22(1):1\u20139. https:\/\/doi.org\/10.1186\/s12885-022-09312-x","journal-title":"BMC Cancer"},{"issue":"6","key":"7890_CR11","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","volume":"4","author":"BJ Caan","year":"2018","unstructured":"Caan BJ, Feliciano EM, Prado CM, Alexeeff S, Kroenke CH, Bradshaw P, Quesenberry CP, Weltzien EK, Castillo AL, Olobatuyi TA, Chen WY (2018) Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol 4(6):798\u2013804. https:\/\/doi.org\/10.1001\/jamaoncol.2018.0137","journal-title":"JAMA Oncol"},{"key":"7890_CR12","doi-asserted-by":"publisher","first-page":"117822342098037","DOI":"10.1177\/1178223420980377","volume":"14","author":"M Asaoka","year":"2020","unstructured":"Asaoka M, Gandhi S, Ishikawa T, Takabe K (2020) Neoadjuvant chemotherapy for breast cancer: past, present, and future. Breast Cancer (Auckl) 14:1178223420980377. https:\/\/doi.org\/10.1177\/1178223420980377","journal-title":"Breast Cancer (Auckl)"},{"issue":"1","key":"7890_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00280-010-1288-y","volume":"67","author":"CM Prado","year":"2011","unstructured":"Prado CM, Lima IS, Baracos VE, Bies RR, McCargar LJ, Reiman T, Mackey JR, Kuzma M, Damaraju VL, Sawyer MB (2011) An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity. Cancer Chemother Pharmacol 67(1):93\u2013101. https:\/\/doi.org\/10.1007\/s00280-010-1288-y","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"7890_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/MCO.0b013e328363bcfb","volume":"6","author":"CM Prado","year":"2013","unstructured":"Prado CM (2013) Body composition in chemotherapy: the promising role of CT scans. Curr Opin Clin Nutr Metab Care 6(5):525\u2013533. https:\/\/doi.org\/10.1097\/MCO.0b013e328363bcfb","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"7890_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10549-014-2843-8","volume":"144","author":"AL Wong","year":"2014","unstructured":"Wong AL, Seng KY, Ong EM, Wang LZ, Oscar H, Cordero MT, Copones R, Fan L, Tan SH, Goh BC, Lee SC (2014) Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients. Breast Cancer Res Treat 144(1):143\u2013152. https:\/\/doi.org\/10.1007\/s10549-014-2843-8","journal-title":"Breast Cancer Res Treat"},{"issue":"32","key":"7890_CR16","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/j.annonc.2021.03.149","volume":"1","author":"A Kurniawan","year":"2021","unstructured":"Kurniawan A, Halim DA, Jodhinata C, Lukito PP, Hatma RD, Adisasmita A, Panigoro SS, Sutandyo N, Tamin TZ, Witjaksono F, Sumantri R (2021) 135P Relationship between low muscle mass pre-chemotherapy with hematological toxicity in breast cancer patients after 3 cycles of chemotherapy. Ann Oncol 1(32):S80. https:\/\/doi.org\/10.1016\/j.annonc.2021.03.149","journal-title":"Ann Oncol"},{"issue":"2","key":"7890_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1001\/jamaoncol.2019.4668","volume":"6","author":"EM Feliciano","year":"2020","unstructured":"Feliciano EM, Chen WY, Lee V, Albers KB, Prado CM, Alexeeff S, Xiao J, Shachar SS, Caan BJ (2020) Body composition, adherence to anthracycline and taxane-based chemotherapy, and survival after nonmetastatic breast cancer. JAMA Oncol 6(2):264\u2013270. https:\/\/doi.org\/10.1001\/jamaoncol.2019.4668","journal-title":"JAMA Oncol"},{"issue":"3","key":"7890_CR18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1158\/1078-0432.CCR-16-0940","volume":"23","author":"SS Shachar","year":"2017","unstructured":"Shachar SS, Deal AM, Weinberg M, Nyrop KA, Williams GR, Nishijima TF, Benbow JM, Muss HB (2017) Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy. Clin Cancer Res 23(3):658\u2013665. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0940","journal-title":"Clin Cancer Res"},{"key":"7890_CR19","unstructured":"National Cancer Institute (2017) Common Terminology Criteria for Adverse Events (CTCAE) v5.0. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_60. Accessed 10 January 2023"},{"issue":"7","key":"7890_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9(7):629\u2013635. https:\/\/doi.org\/10.1016\/S1470-2045(08)70153-0","journal-title":"Lancet Oncol"},{"issue":"9","key":"7890_CR21","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1007\/s00520-019-05279-x","volume":"28","author":"A Ueno","year":"2020","unstructured":"Ueno A, Yamaguchi K, Sudo M, Imai S (2020) Sarcopenia as a risk factor of severe laboratory adverse events in breast cancer patients receiving perioperative epirubicin plus cyclophosphamide therapy. Support Care Cancer 28(9):4249\u20134254. https:\/\/doi.org\/10.1007\/s00520-019-05279-x","journal-title":"Support Care Cancer"},{"issue":"14","key":"7890_CR22","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1158\/1078-0432.CCR-16-2266","volume":"23","author":"SS Shachar","year":"2017","unstructured":"Shachar SS, Deal AM, Weinberg M, Williams GR, Nyrop KA, Popuri K, Choi SK, Muss HB (2017) Body composition as a predictor of toxicity in patients receiving anthracycline and taxane\u2013based chemotherapy for early-stage breast cancer. Clin Cancer Res 23(14):3537\u20133543. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2266","journal-title":"Clin Cancer Res"},{"key":"7890_CR23","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3389\/fonc.2020.01576","volume":"10","author":"D Martin","year":"2020","unstructured":"Martin D, von der Gr\u00fcn J, R\u00f6del C, Fokas E (2020) Sarcopenia is associated with hematologic toxicity during chemoradiotherapy in patients with anal carcinoma. Front Oncol 10:1576. https:\/\/doi.org\/10.3389\/fonc.2020.01576","journal-title":"Front Oncol"},{"issue":"4","key":"7890_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/01635581.2014.894103","volume":"66","author":"M Barret","year":"2014","unstructured":"Barret M, Antoun S, Dalban C, Malka D, Mansourbakht T, Zaanan A, Latko E, Taieb J (2014) Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer. Nutr Cancer 66(4):583\u2013589. https:\/\/doi.org\/10.1080\/01635581.2014.894103","journal-title":"Nutr Cancer"},{"issue":"4","key":"7890_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1200\/JCO.2022.40.4_suppl.084","volume":"40","author":"M Lei","year":"2022","unstructured":"Lei M, Nipp RD, Tavares E, Lou U, Grasso E, Mui SY, Marquardt JP, Best TD, Van Seventer EE, Saraf A, Tahir I (2022) Associations of sarcopenia with hematologic toxicity, treatment intensity, and healthcare utilization in patients with metastatic colorectal cancer. J Clin Oncol 40(4):82\u201384. https:\/\/doi.org\/10.1200\/JCO.2022.40.4_suppl.084","journal-title":"J Clin Oncol"},{"key":"7890_CR26","doi-asserted-by":"publisher","first-page":"111379","DOI":"10.1016\/j.exger.2021.111379","volume":"150","author":"SH Tseng","year":"2021","unstructured":"Tseng SH, Lee WJ, Peng LN, Lin MH, Chen LK (2021) Associations between hemoglobin levels and sarcopenia and its components: results from the I-Lan longitudinal study. Exp Gerontol 150:111379. https:\/\/doi.org\/10.1016\/j.exger.2021.111379","journal-title":"Exp Gerontol"},{"key":"7890_CR27","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1155\/2022\/2202511","volume":"24","author":"F Zeng","year":"2022","unstructured":"Zeng F, Huang L, Zhang Y, Hong X, Weng S, Shen X, Zhao F, Yan S (2022) Additive effect of sarcopenia and anemia on the 10-year risk of cardiovascular disease in patients with type 2 diabetes. J Diabetes Res 24:2022. https:\/\/doi.org\/10.1155\/2022\/2202511","journal-title":"J Diabetes Res"},{"issue":"12","key":"7890_CR28","doi-asserted-by":"publisher","first-page":"105405","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105405","volume":"29","author":"Y Yoshimura","year":"2020","unstructured":"Yoshimura Y, Wakabayashi H, Nagano F, Bise T, Shimazu S, Shiraishi A (2020) Low hemoglobin levels are associated with sarcopenia, dysphagia, and adverse rehabilitation outcomes after stroke. J Stroke Cerebrovasc Dis 29(12):105405. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105405","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"7890_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jcgg.2015.03.007","volume":"6","author":"JH Moon","year":"2015","unstructured":"Moon JH, Kong MH, Kim HJ (2015) Relationship between low muscle mass and anemia in Korean elderly men: Using the Korea National Health and Nutrition Examination Survey (KNHANES IV\u2013V). J Clin Gerontol Geriatr 6(4):115\u2013119. https:\/\/doi.org\/10.1016\/j.jcgg.2015.03.007","journal-title":"J Clin Gerontol Geriatr"},{"key":"7890_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.breast.2021.12.014","volume":"61","author":"E Deluche","year":"2022","unstructured":"Deluche E, Lachatre D, Di Palma M, Simon H, Tissot V, Vansteene D, Meingan P, Mohebi A, Lenczner G, Pigneur F, Goldwasser F (2022) Is sarcopenia a missed factor in the management of patients with metastatic breast cancer? Breast 61:84\u201390. https:\/\/doi.org\/10.1016\/j.breast.2021.12.014","journal-title":"Breast"},{"issue":"3","key":"7890_CR31","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/ijerph19031769","volume":"19","author":"AR Curtis","year":"2022","unstructured":"Curtis AR, Livingstone KM, Daly RM, Marchese LE, Kiss N (2022) Associations between dietary patterns and malnutrition, low muscle mass and sarcopenia in adults with cancer: a scoping review. Int J Environ Res Public Health 19(3):1769. https:\/\/doi.org\/10.3390\/ijerph19031769","journal-title":"Int J Environ Res Public Health"},{"key":"7890_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.breast.2019.02.001","volume":"44","author":"ME Spei","year":"2019","unstructured":"Spei ME, Samoli E, Bravi F, La Vecchia C, Bamia C, Benetou V (2019) Physical activity in breast cancer survivors: a systematic review and meta-analysis on overall and breast cancer survival. Breast 44:144\u2013152. https:\/\/doi.org\/10.1016\/j.breast.2019.02.001","journal-title":"Breast"},{"issue":"3","key":"7890_CR33","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jgo.2018.10.009","volume":"10","author":"GR Williams","year":"2019","unstructured":"Williams GR, Rier HN, McDonald A, Shachar SS (2019) Sarcopenia & aging in cancer. J Geriatr Oncol 10(3):374\u2013377. https:\/\/doi.org\/10.1016\/j.jgo.2018.10.009","journal-title":"J Geriatr Oncol"},{"issue":"6","key":"7890_CR34","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.21873\/anticanres.11660","volume":"37","author":"H Miyata","year":"2017","unstructured":"Miyata H, Sugimura K, Motoori M, Fujiwara Y, Omori T, Yanagimoto Y, Ohue M, Yasui M, Miyoshi N, Tomokuni A, Akita H (2017) Clinical assessment of sarcopenia and changes in body composition during neoadjuvant chemotherapy for esophageal cancer. Anticancer Res 37(6):3053\u20133059. https:\/\/doi.org\/10.21873\/anticanres.11660","journal-title":"Anticancer Res"},{"issue":"6","key":"7890_CR35","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.surg.2019.07.033","volume":"166","author":"T Ishida","year":"2019","unstructured":"Ishida T, Makino T, Yamasaki M, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y, Motoori M, Kimura Y, Nakajima K, Mori M (2019) Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy. Surgery 166(6):1041\u20131047. https:\/\/doi.org\/10.1016\/j.surg.2019.07.033","journal-title":"Surgery"},{"issue":"1","key":"7890_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10147-019-01544-5","volume":"25","author":"T Yumioka","year":"2020","unstructured":"Yumioka T, Honda M, Nishikawa R, Teraoka S, Kimura Y, Iwamoto H, Morizane S, Hikita K, Takenaka A (2020) Sarcopenia as a significant predictive factor of neutropenia and overall survival in urothelial carcinoma patients underwent gemcitabine and cisplatin or carboplatin. Int J Clin Oncol 25(1):158\u2013164. https:\/\/doi.org\/10.1007\/s10147-019-01544-5","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"7890_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-021-01876-5","volume":"16","author":"MP Nilsson","year":"2021","unstructured":"Nilsson MP, Johnsson A, Scherman J (2021) Sarcopenia and dosimetric parameters in relation to treatment-related leukopenia and survival in anal cancer. Radiat Oncol 16(1):1\u20139. https:\/\/doi.org\/10.1186\/s13014-021-01876-5","journal-title":"Radiat Oncol"},{"issue":"3","key":"7890_CR38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.critrevonc.2013.12.006","volume":"90","author":"GH Lyman","year":"2014","unstructured":"Lyman GH, Abella E, Pettengell R (2014) Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: a systematic review. Crit Rev Oncol Hematol 90(3):190\u2013199. https:\/\/doi.org\/10.1016\/j.critrevonc.2013.12.006","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07890-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07890-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07890-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T21:02:06Z","timestamp":1715720526000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07890-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["7890"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07890-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,24]]},"assertion":[{"value":"9 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was performed in accordance with the institutional review board and ethical standards of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The institutional review board of the hospital of the Yonsei University Health System approved the study protocol (#4-2021-0452).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was waived because of the retrospective nature of the study and the minimal risks to participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"419"}}